These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5107835)

  • 1. Lymphadenectomy in pelvic exenteration for recurrent cervix cancer.
    Barber HR; Jones W
    JAMA; 1971 Mar; 215(12):1945-9. PubMed ID: 5107835
    [No Abstract]   [Full Text] [Related]  

  • 2. Can laparoscopic para-aortic lymphadenectomy help to select patients with pelvic relapse of cervical cancer eligible for pelvic exenteration?
    Dargent D; Ansquer Y; Mathevet P
    Gynecol Oncol; 1999 Apr; 73(1):172. PubMed ID: 10094905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of loco-regional recurrences of cervix cancers].
    Bobin JY; Romestaing P; Gérard JP
    Ann Chir; 1999; 53(9):904. PubMed ID: 10633941
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pelvic exenteration for carcinoma of the uterine cervix (author's transl)].
    Mayer M; Bobin JY; Colon J; Borg G
    Bull Cancer; 1980; 67(1):70-7. PubMed ID: 7362891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current role of exenteration for the treatment of malignant pelvic tumors].
    Symmonds RE
    Gynakologe; 1981 Sep; 14(3):170-6. PubMed ID: 7286790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer of the cervix uteri].
    Dargent M
    Lyon Chir; 1970; 66(6):457-63. PubMed ID: 4993742
    [No Abstract]   [Full Text] [Related]  

  • 8. Our approach to cancer of the cervix.
    Barber HR
    Med Times; 1972 Jan; 100(1):118-9 passim. PubMed ID: 5061502
    [No Abstract]   [Full Text] [Related]  

  • 9. Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors.
    Forner DM; Lampe B
    Am J Obstet Gynecol; 2011 Aug; 205(2):148.e1-6. PubMed ID: 21640963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic indications in cancer of the uterine cervix].
    Michel G; Lacour J
    Maroc Med; 1972 Nov; 52(562):621-31. PubMed ID: 4665021
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early stages of uterine cervix carcinoma: surgery and radiotherapy (author's transl)].
    Pilleron JP; Durand JC; Cleophax JP; Hamelin JP; Garcia JC; Lefranc JP
    Bull Cancer; 1980; 67(1):48-57. PubMed ID: 7362888
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical treatment of carcinoma of the cervix, recurrent after irradiation or combination of irradiation and surgery.
    Brunschwig A
    Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):365-70. PubMed ID: 6020184
    [No Abstract]   [Full Text] [Related]  

  • 13. Is positive pelvic lymphadenopathy a contraindication to radical surgery in recurrent cervical carcinoma?
    Creasman WT; Rutledge F
    Gynecol Oncol; 1974 Dec; 2(4):482-5. PubMed ID: 4463149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The uterine cervix. Basis for pelvic lymphadenectomy].
    Chevallier JM
    Soins Chir; 1996 Apr; (176):45-8. PubMed ID: 8717724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Considerations on 241 pelvic eviscerations].
    Ingiulla W; De Laurentiis G
    Riv Ostet Ginecol; 1967 Feb; 22(2):85-92. PubMed ID: 5601271
    [No Abstract]   [Full Text] [Related]  

  • 17. [New approaches in "conventional" surgery of uterine cervix cancer].
    Morice P; Castaigne D
    Cancer Radiother; 2000; 4(2):122-6. PubMed ID: 10812357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration for primary carcinoma of the uterine cervix.
    Deckers PJ; Ketcham AS; Sugerbaker EV; Hoye RC; Thomas LB
    Obstet Gynecol; 1971 May; 37(5):647-59. PubMed ID: 5091743
    [No Abstract]   [Full Text] [Related]  

  • 19. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for carcinoma of the cervix.
    Ingersoll FM; Ulfelder H
    N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.